Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ

Harvey, Adam, Mielke, Nicholas, Grimstead, Julia W, Jones, Rhiannon E, Nguyen, Thanh, Mueller, Matthew, Baird, Duncan M ORCID: and Hendrickson, Eric A. 2018. PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ. Oncotarget 9 (78) , pp. 34821-34837. 10.18632/oncotarget.26201

[thumbnail of 26201-1014217-3-PB.pdf]
PDF - Published Version
Available under License Creative Commons Attribution.

Download (6MB) | Preview


Poly-ADP ribose polymerase 1 (PARP1) is clinically important because of its synthetic lethality with breast cancer allele 1 and 2 mutations, which are causative for inherited breast and ovarian cancers. Biochemically, PARP1 is a single-stranded DNA break repair protein that is needed for preserving genomic integrity. In addition, PARP1 has been implicated in a veritable plethora of additional cellular pathways and thus its precise contribution(s) to human biology has remained obscure. To help address this deficiency, we utilized gene editing to construct genetically-null PARP1 human cancer cells. We found a minor role for PARP1 in an alternative form of DNA double-strand break (DSB) repair, but only when these cells were deficient for the classical form of DSB repair. Despite being proficient for DSB repair, however, cell cycle progression defects and elevated endogenous DNA damage signaling were observed. These deficiencies were instead linked to telomere defects, where PARP1-/- cells had short telomeres that co-localized with markers of endogenous DNA damage and were compromised in their ability to escape a telomere-driven crisis. Our data suggest that while PARP1 does not participate significantly in DNA DSB repair itself, it does prevent the incidence of telomeric DSBs, which, in turn, can drive genomic instability.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Impact Journals LLC
ISSN: 1949-2553
Date of First Compliant Deposit: 13 December 2018
Date of Acceptance: 15 September 2018
Last Modified: 04 May 2023 06:26

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics